Knight to Present at the 2023 RBC Capital Markets Global Healthcare Conference in New York City Pharmaceutical Investing
Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access to Next-Generation Sequencing-Based Testing for Cancer Patients in International Markets Medical Device Investing
Salix Pharmaceuticals to Deliver Podium Presentation at Digestive Disease Week 2023 Pharmaceutical Investing
Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering Pharmaceutical Investing
RYALTRIS®, a new combination prescription nasal spray for moderate to severe seasonal allergic rhinitis , now available across Canada Pharmaceutical Investing
